- Approach to patient with diffuse interstitial lung disease
- Thoracic Imaging for Diffuse ILD and bronchiolar disorders
- Bronchoalveolar lavage. (BAL) for Diffuse ILD
- Genetics of ILD
- Pathology of Diffuse ILD
- Immunosuppressive and cytotoxic drug therapy for Diffuse ILD
- Sarcoidosis: pathogenesis, epidemiology
- Pulmonary Sarcoidosis
- Extrapulmonary sarcoidosis
- Hypersensitivity pneumonitis
- Berylliosis
- Hard metal pneumoconiosis
- Silicosis and Asbestosis
- Idiopathic pulmonary. fibrosis (IPF)
- Nonspecific Interstitial Pneumonitis
- Respiratory bronchiolitis interstitial lung disease (RBILD) and desquamative interstitial pneumonia (DIP)
- Acute interstitial pneumonia (AIP)
- Lymphocytic Interstitial Pneumonitis (LIP) and other pulmonary lymphoproliferative disorders
- Collagen-vascular disease-associated pulmonary fibrosis
- Other pleuropulmonary complications of CVDs
- Cryptogenic Organizing Pneumonia (COP) and other causes of organizing pneumonia Obliterative bronchiolitis: classification, causes, overview
- Obliterative bronchiolitis following lung or heart-lung transplantation
- Pulmonary complications of bone marrow transplantation
- Pulmonary and airway complications related to September 11th
- Pathogenesis and Epidemiology of ANCA-associated Vasculitides
- WegenerÆs Granulomatosis
- Churg-Strauss Vasculitis. Microscopic polyangiitis
- Pulmonary Capillaritis
- Anti-GBM antibody disease (GoodpastureÆs Syndrome)
- BehcetÆs Disease
- Eosinophilic pneumonias and syndromes
- Langerhans cell granulomatosis (LCG)
- Lymphangioleiomyomatosis
- Pulmonary alveolar proteinosis (PAP)
- Pulmonary and tracheobronchial involvement with amyloidosis
- Drug -induced pulmonary disorders
- Joseph P. Lynch, III, UCLA, Los Angeles, California, USA
